Objective:
To assess the impact of artificial intelligence on the accuracy and efficiency of human graders in detecting retinal disease biomarkers in OCT scans.
Key Findings:
- Use of AI reports improved disease detection by 42% overall.
- AI integration enhanced accuracy and consistency in identifying retinal biomarkers.
Interpretation:
The study indicates that AI serves as a tool to empower clinicians rather than replace them, improving diagnostic capabilities in a community-based setting.
Limitations:
- Study limited to specific OCT volumes and may not generalize to all retinal disease cases.
- Results based on a simulated community-based setting may differ in real-world applications.
Conclusion:
AI can significantly enhance the detection of retinal disease biomarkers, supporting clinicians in their evaluations.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.